½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1338963

ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® ¸®Æ÷Æ® : ÄÄÆ÷³ÍÆ®º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2032³â)

Artificial Intelligence (AI) in Medical Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Hardware, and Services); By Application; By End User; By Region; Segment Forecast, 2023 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 116 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°èÀÇ ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 307¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Á¶»ç ¸®Æ÷Æ®´Â ÇöÀçÀÇ ½ÃÀå ¿ªÇÐÀ» »ó¼¼ ÀλçÀÌÆ®ÇÏ°í, ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇÏ°í ÀÖ½À´Ï´Ù.

AI ±â¹Ý ±â¼ú äÅÃÀ» ÃËÁøÇϱâ À§ÇÑ Á¤ºÎ ±¸»ó Áõ°¡, ¾÷¹« ºÎ´ãÀ» ÁÙÀ̱â À§ÇÑ ¹æ»ç¼± Àü¹®ÀÇÀÇ Ã¤Åà Áõ°¡, ºòµ¥ÀÌÅÍÀÇ ±Þ°ÝÇÑ ¿µÇâ·Â Áõ°¡, »õ·Î¿î AI ±â¹Ý ½ºÅ¸Æ®¾÷¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ÀÇ·á Áø´Ü¿¡ AIÀÇ Àû¿ë Áõ°¡´Â ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.

Áõ°¡ÇÏ´Â º¹ÀâÇÏ°í ¹æ´ëÇÑ ÀÇ·á Áø´Ü µ¥ÀÌÅ͸¦ È¿À²ÀûÀ¸·Î °ü¸®ÇÏ°í Ä¡·á ÀýÂ÷¸¦ °­È­ÇØ¾ß ÇÒ Çʿ伺ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÁÖ¿ä ±â¾÷ÀÌ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ß¿¡ ÁýÁßÇÏ°í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2022³â 9¿ù À§ÇÁ·Î¿Í GEÇコÄɾî´Â '¿ÉƼ¸¶ IGS 320'À̶ó´Â À̸§ÀÇ Àεµ ÃÖÃÊÀÇ AI ±â¹Ý Ä«Å×ÅÍ ·¦À» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¿¬±¸¼Ò´Â ½ÉÀå Àü¹®ÀÇ¿Í È¯ÀÚ¿¡°Ô ƯÁ¤ Ä¡·á ¿ä¹ý°ú ÇÁ·ÎÅäÄÝÀ» Áö¿øÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

¼¼°è ¿¬±¸ÀÚµéÀº °£, ÇǺÎ, ½ÉÀå, ¾ËÃ÷ÇÏÀÌ¸Ó µî Á¶±â Áø´ÜÀÌ ÇÊ¿äÇÑ Áúº´À» °¨ÁöÇϱâ À§ÇØ µö·¯´×, ¸Ó½Å·¯´× ¸ðµ¨ µî ´Ù¾çÇÑ À¯ÇüÀÇ AI ±â¹Ý ±â¼úÀ» »ç¿ëÇÏ°í ÀÖ½À´Ï´Ù. µû¶ó¼­ º¼Ã÷¸¸ ¸Ó½Å, ¼­Æ÷Æ® º¤ÅÍ ¸Ó½Å, °áÁ¤ Æ®¸®, ·ÎÁö½ºÆ½ ȸ±Í, Àΰø½Å°æ¸Á, KÃÖ±ÙÁ¢ ÀÌ¿ô°ú °°Àº ±â¼úÀº ³ôÀº Á¤È®µµ·Î Ç¥½ÃµÇ´Â °ÍÀ¸·Î ÁöÁö¹Þ°í ÀÖ½À´Ï´Ù.

¾ÕÀ¸·Î ¸î³â¾È¿¡ AI ¾Ë°í¸®ÁòÀº ÇϳªÀÇ À̹ÌÁö³ª µ¥ÀÌÅÍ ¼¼Æ®¿¡¼­ ÇÑ °¡Áö º´º¯»Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ º´º¯À» È¿°úÀûÀ¸·Î ÀνÄÇÒ ¼ö ÀÖ°Ô µÉ °ÍÀÔ´Ï´Ù. ÇÑ ÀåÀÇ »çÁø¿¡¼­ ¿©·¯ º´º¯À» °¨ÁöÇϱâ À§Çؼ­´Â ¹æ»ç¼±°ú Àǻ簡 ÇÑ ÀåÀÇ »çÁø¿¡ ³ªÅ¸³¯ ¼ö ÀÖ´Â ¸ðµç ÀÌ»ó ¡ÈÄ¿¡ ´ëÇØ »ó¼¼ÇÑ ÁÖ¼®À» ´Þ¾Æ¾ß Çϸç, ±× °á°ú ÀÇ·á Áø´Ü ºÐ¾ß¿¡¼­ °í±Þ AI ¼Ö·ç¼ÇÀÇ µµÀÔÀÌ °¡¼ÓÈ­µÉ °ÍÀÔ´Ï´Ù.

ÀÇ·á Áø´Ü ºÐ¾ßÀÇ ÀΰøÁö´É(AI) ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

ÀÎÀ§ÀûÀÎ ½Ç¼ö¿Í ÀÇ·áÁø ºÎÁ·À» ÁÙÀ̱â À§ÇØ ¸¹Àº ¸¸¼ºÁúȯ°ú ±Þ¼ºÁúȯ Áø´Ü¿¡ µµÀÔÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, 2022³â ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

»ýü³» Áø´Ü ºÐ¾ß°¡ 2022³â °¡Àå Å« ½ÃÀå ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇߴµ¥, ÀÌ´Â ÁÖ·Î Ä¡·á È¿°ú¸¦ ³ôÀ̱â À§ÇØ ÁÖ¿ä ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµé »çÀÌ¿¡¼­ Àαâ¿Í º¸±ÞÀÌ Áõ°¡ÇÏ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

Á¢°´(Hoapitality) ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °ÇÀüÇÑ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ÁÖ·Î º´¿ø¿¡¼­ ÀÌ·ç¾îÁö´Â ¼ö¼ú °Ç¼ö°¡ Áõ°¡ÇÏ°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

ºÏ¹Ì´Â ÷´Ü ±â¼úÀÇ ºü¸¥ µµÀÔ°ú Àß Á¤ºñµÈ ÀÇ·á ÀÎÇÁ¶ó·Î ÀÎÇØ 2022³â ¼¼°è ½ÃÀå¿¡¼­ °¡Àå ³ôÀº Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå ÀλçÀÌÆ®

  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚ ½º³À¼ô
  • ÀÇ·á Áø´Ü ½ÃÀå ¿ªÇп¡¼­ ÀΰøÁö´É(AI)
    • ÃËÁø¿äÀΰú ±âȸ
      • ¸¸¼ºÁúȯ °ü¸®¿¡¼­ AIÀÇ »ç¿ë Áõ°¡
      • ½º¸¶Æ®ÇÑ ÀüÀÚ°Ç°­±â·Ï¿¡ ´ëÇÑ ¾×¼¼½º
    • ¾ïÁ¦¿äÀΰú °úÁ¦
      • °íµµ·Î ±ÔÁ¦µÈ ¾÷°è
  • PESTEL ºÐ¼®
  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå ÃÖÁ¾»ç¿ëÀÚÀÇ µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ¼ÒÇÁÆ®¿þ¾î
  • Çϵå¿þ¾î
  • ¼­ºñ½º

Á¦6Àå ¼¼°èÀÇ ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • »ýü³»Áø´Ü
  • ü¿ÜÁø´ÜÇÐ

Á¦7Àå ¼¼°èÀÇ ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • º´¿ø
  • ¿µ»ó Áø´Ü ¼¾ÅÍ
  • Áø´Ü ¿¬±¸¼Ò
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032
  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ºÏ¹Ì : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ºÏ¹Ì : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¹Ì±¹
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ij³ª´Ù
  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - À¯·´
    • À¯·´ : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • À¯·´ : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • À¯·´ : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¿µ±¹
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ÇÁ¶û½º
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - µ¶ÀÏ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ½ºÆäÀÎ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ³×´ú¶õµå
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ·¯½Ã¾Æ
  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ¾ÖÇø®ÄÉÀ̼Ǻ°, 2019-2032³â
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - Áß±¹
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - Àεµ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¸»·¹À̽þÆ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ÀϺ»
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - Àεµ³×½Ã¾Æ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - Çѱ¹
  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå -UAE
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - À̽º¶ó¿¤
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÄÄÆ÷³ÍÆ®º°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¸ß½ÃÄÚ
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ºê¶óÁú
    • ÀÇ·á Áø´Ü¿ë ÀΰøÁö´É(AI) ½ÃÀå - ¾Æ¸£ÇîƼ³ª

Á¦9Àå °æÀï ±¸µµ

  • È®Àå°ú Àμö ºÐ¼®
    • È®´ë
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦10Àå ±â¾÷ °³¿ä

  • Intel Corporation
  • Google
  • IBM Corporation
  • Microsoft Corporation
  • Enlitic Inc
  • Siemens Healthcare
  • Zebra Medical Vision Inc.
  • Riverain Technologies
  • Imagen Technologies
  • GE Healthcare
  • Digital Diagnostics
  • HeartFlow
  • Arterys
  • International Business Machines
  • VUNO Inc.
  • NovaSignal Corporation
  • Agfa-Gevaert
KSA 23.10.05

The global artificial intelligence (AI) in medical diagnostics market size is expected to reach USD 30.76 Billion by 2032, according to a new study by Polaris Market Research. The report "Artificial Intelligence (AI) in Medical Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Component (Software, Hardware, and Services); By Application; By End User; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Growing applications of AI in medical diagnostics due to numerous factors including increasing government initiatives to fuel the adoption of AI-based technologies, rising adoption by radiologists to reduce the work pressure, the surging influence of big data, and funding for new AI-based startups are major prominent factors driving the global market growth.

With the emerging need to efficiently manage the rising volume of complex and large medical diagnostic data and enhance treatment procedures, the key players are becoming more focused towards developing innovative solutions that is positively impacting the market. For instance, in September 2022, Wipro & GE Healthcare, introduced its 1st Indian made AI-based cath-lab named 'Optima IGS 320'. This lab, company aims to support cardiologists & the patients with specific treatment therapies and protocols.

The researchers all over the world have used various types of AI-based techniques such as deep learning and machine learning models to detect the diseases including liver, skin, heart, Alzheimer, and many others that requires early diagnosis. Hence, the techniques like Boltzmann machine, support vector machine, decision tree, logistic regression, artificial neural network, and K nearest neighbor have gained traction to be presented with high accuracies.

In the coming years, AI algorithms will effectively recognize not just one but large range of conditions from single image or data set. Detecting multiple pathologies from same images that requires radiologists to provide the detailed annotations for each possible abnormality in a single photo, which results in higher incorporation of advanced AI solutions in medical diagnostics.

Artificial Intelligence (AI) in Medical Diagnostics Market Report Highlights

Software segment accounted for highest market share in 2022, on account of its growing adoption to diagnose large number of chronic and acute diseases to reduce human errors and lack of care providers

In vivo diagnostics segment held the maximum market revenue share in 2022, which is mainly driven by its growing popularity and prevalence among large healthcare providers to enhance the treatment efficacy

Hospitals segment is projected to grow at healthy CAGR during the forecast period, mainly due to rise in the number of surgical procedures being performed in hospitals

North America region dominated the global market with highest share in 2022, owing to quick adoption of advanced technologies and availability to well-developed healthcare infrastructure

The global key market players include: Microsoft Corporation, Imagen Technologies, International Business Machines Corporation, Zebra Medical Vision, and Riverian Technologies

Polaris Market Research has segmented the artificial intelligence (AI) in medical diagnostics market report based on component, application, end user, and region:

Artificial Intelligence (AI) in Medical Diagnostics, Component Outlook (Revenue - USD Billion, 2019 - 2032)

  • Software
  • Hardware
  • Services

Artificial Intelligence (AI) in Medical Diagnostics, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • In Vivo Diagnostics
  • In Vitro Diagnostics

Artificial Intelligence (AI) in Medical Diagnostics, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Diagnostic Imaging Centers
  • Diagnostic Laboratories
  • Others

Artificial Intelligence (AI) in Medical Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Artificial Intelligence (AI) in Medical Diagnostics Market Insights

  • 4.1. Artificial Intelligence (AI) in Medical Diagnostics Market - End User Snapshot
  • 4.2. Artificial Intelligence (AI) in Medical Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing use of AI in chronic disease management
      • 4.2.1.2. Access to smart electronic medical records
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Highly regulated industry
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Artificial Intelligence (AI) in Medical Diagnostics Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Component

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
  • 5.3. Software
    • 5.3.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Software, by Region, 2019-2032 (USD Billion)
  • 5.4. Hardware
    • 5.4.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Hardware, by Region, 2019-2032 (USD Billion)
  • 5.5. Services
    • 5.5.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Services, by Region, 2019-2032 (USD Billion)

6. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
  • 6.3. In Vivo Diagnostics
    • 6.3.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by In Vivo Diagnostics, by Region, 2019-2032 (USD Billion)
  • 6.4. In Vitro Diagnostics
    • 6.4.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by In Vitro Diagnostics, by Region, 2019-2032 (USD Billion)

7. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Diagnostics Imaging Centers
    • 7.4.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Diagnostics Imaging Centers, By Region, 2019-2032 (USD Billion)
  • 7.5. Diagnostic Laboratories
    • 7.5.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Diagnostic Laboratories, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Artificial Intelligence (AI) in Medical Diagnostics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Artificial Intelligence (AI) in Medical Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Artificial Intelligence (AI) in Medical Diagnostics Market - North America
    • 8.3.1. North America: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
    • 8.3.2. North America: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
    • 8.3.3. North America: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Artificial Intelligence (AI) in Medical Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Artificial Intelligence (AI) in Medical Diagnostics Market - Canada
      • 8.3.5.1. Canada: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Artificial Intelligence (AI) in Medical Diagnostics Market - Europe
    • 8.4.1. Europe: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Artificial Intelligence (AI) in Medical Diagnostics Market - UK
      • 8.4.4.1. UK: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Artificial Intelligence (AI) in Medical Diagnostics Market - France
      • 8.4.5.1. France: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Artificial Intelligence (AI) in Medical Diagnostics Market - Germany
      • 8.4.6.1. Germany: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Artificial Intelligence (AI) in Medical Diagnostics Market - Italy
      • 8.4.7.1. Italy: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Artificial Intelligence (AI) in Medical Diagnostics Market - Spain
      • 8.4.8.1. Spain: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Artificial Intelligence (AI) in Medical Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Artificial Intelligence (AI) in Medical Diagnostics Market - Russia
      • 8.4.10.1. Russia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Artificial Intelligence (AI) in Medical Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Artificial Intelligence (AI) in Medical Diagnostics Market - China
      • 8.5.4.1. China: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Artificial Intelligence (AI) in Medical Diagnostics Market - India
      • 8.5.5.1. India: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Artificial Intelligence (AI) in Medical Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Artificial Intelligence (AI) in Medical Diagnostics Market - Japan
      • 8.5.7.1. Japan: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Artificial Intelligence (AI) in Medical Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Artificial Intelligence (AI) in Medical Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Artificial Intelligence (AI) in Medical Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Artificial Intelligence (AI) in Medical Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Artificial Intelligence (AI) in Medical Diagnostics Market - UAE
      • 8.6.5.1. UAE: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Artificial Intelligence (AI) in Medical Diagnostics Market - Israel
      • 8.6.6.1. Israel: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Artificial Intelligence (AI) in Medical Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Artificial Intelligence (AI) in Medical Diagnostics Market - Latin America
    • 8.7.1. Latin America: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Artificial Intelligence (AI) in Medical Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Artificial Intelligence (AI) in Medical Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Artificial Intelligence (AI) in Medical Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Artificial Intelligence (AI) in Medical Diagnostics Market, by Component, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Artificial Intelligence (AI) in Medical Diagnostics Market, by End User, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Artificial Intelligence (AI) in Medical Diagnostics Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Intel Corporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Google
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. IBM Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Microsoft Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Enlitic Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Siemens Healthcare
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Zebra Medical Vision Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Riverain Technologies
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Imagen Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. GE Healthcare
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Digital Diagnostics
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. HeartFlow
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Arterys
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. International Business Machines
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. VUNO Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. NovaSignal Corporation
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. Agfa-Gevaert
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦